
Oriak Fct 300mg Tablet
Marketer
Novartis India Ltd
Salt Composition
Tenofovir Alafenamide (300mg)
Overview Oriak Fct 300mg Tablet
Lamivudine 300mg tablets combat HIV and chronic hepatitis B infections by hindering viral replication within human cells, thereby reducing viral load and aiding infection clearance. Dosage and treatment duration should strictly adhere to your physician's instructions; complete the prescribed course regardless of symptom improvement. Administer the medication with food to optimize absorption. Continue treatment until medically advised to discontinue. Potential side effects include headache, nausea, diarrhea, abdominal pain, joint pain, and indigestion. Persistent or bothersome side effects warrant medical attention. Though generally mild, severe reactions like skin rashes or liver injury are rare, necessitating close monitoring, particularly early in treatment. Pre-existing skin conditions, liver or kidney impairment should be disclosed to your doctor prior to commencing treatment. Regular blood tests to assess blood counts and liver function may be required. Alcohol consumption should be avoided due to increased liver damage risk. Pregnant or lactating individuals must consult their doctor before use. Individuals with HIV should practice safe sex, avoiding unprotected intercourse and sharing personal items to minimize transmission risk. Discuss safe sex practices, such as condom use, with your doctor.
Primary Ingredients of Oriak Fct 300mg Tablet
No text was provided to rewrite.
Uses of Oriak Fct 300mg Tablet
Managing persistent hepatitis B virus (HBV) infection
Major Benefits of Oriak Fct 300mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. The Oriak Fct 300mg Tablet should be administered with a meal.
Common Side effects of Oriak Fct 300mg Tablet:
- Headache
- Diarrhea
- Nausea
- Fatigue
- Abdominal pain
- Cough
- Back pain
- Indigestion
- Joint pain
How to use Oriak Fct 300mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take the 300mg Oriak Fct Tablet with a meal.
How Oriak Fct 300mg Tablet works:
The antiviral drug Oriak Fct 300mg Tablet inhibits viral replication within human cells, thereby halting further viral production and resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oriak Fct 300mg Tablet lacks established safety data. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The use of Oriak Fct 300mg Tablets during pregnancy is typically regarded as safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; data from human trials, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Oriak Fct 300mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Oriak Fct 300mg tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Oriak Fct 300mg Tablets. Dosage modification may be necessary. A physician's consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Oriak Fct 300mg Tablet in individuals with liver impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, though further information is limited. Physician consultation is recommended.
What if you forget to take Oriak Fct 300mg Tablet :
Should you forget a dose of Oriak Fct 300mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oriak Fct 300mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Base analog |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Action Category | Reverse transcriptase inhibitors (RTIs) targeting nucleosides/nucleotides |
